Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingrid Pabinger

Showing results (101-110 of 367) with videos related to

Pageof 37
Sort By:
Pediatric Blood & Cancer|August 26, 2006
Flow cytometric evaluation of platelet activation in chronic autoimmune thrombocytopeniaSimon Panzer, Lisa Höcker, Rainer Vormittag, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 17, 2025
Estimating the Factor VIII-Equivalent Activity of Emicizumab Using Global Assays of HaemostasisDaniel Kraemmer, Cihan Ay, Judit Rejtő, et al.
Scientific Reports|June 22, 2021
Bleeding outcomes and factor utilization after switching to an extended half-life product for prophylaxis in haemophilia A in AustriaCihan Ay, Clemens Feistritzer, Joachim Rettl, et al.
Journal of Thrombosis and Haemostasis : JTH|March 16, 2023
Risk factors for future bleeding in patients with mild bleeding disorders: longitudinal data from the Vienna Bleeding BiobankDino Mehic, Georg Neubauer, Florian Janig, et al.
Hamostaseologie|June 9, 2026
Risk Factors, Biomarkers, and Risk Assessment Models for Prediction of Venous Thromboembolism in Ambulatory Patients with Advanced Lung CancerLeyla Ay, Florian Moik, Thorsten Füreder, et al.
Wiener Klinische Wochenschrift|January 18, 2012
Inhibitor development in two patients with mild haemophilia A - spontaneous disappearance and no recurrence of the inhibitor after re-challengeSylvia Reitter-Pfoertner, Birgit Horvath, Klaus Lechner, et al.
Seminars in Thrombosis and Hemostasis|April 4, 2025
Hemostatic and Inflammatory Biomarkers are Associated with Functional Limitations after Venous Thromboembolism: A Prospective Cohort StudyDaniel Steiner, Stephan Nopp, Timothy Hoberstorfer, et al.
Thrombosis Research|March 3, 2007
The clinical significance of anti-prothrombin antibodies for risk assessment of thromboembolism in patients with lupus anticoagulantThomas Sailer, Rainer Vormittag, Claudia Zoghlami, et al.
Haematologica|March 7, 2007
Venous thromboembolism--a manifestation of the metabolic syndromeCihan Ay, Theres Tengler, Rainer Vormittag, et al.
Thrombosis and Haemostasis|May 6, 2006
Anti-beta2-glycoprotein I antibodies are associated with pregnancy loss in women with the lupus anticoagulantThomas Sailer, Claudia Zoghlami, Christine Kurz, et al.
Pageof 37

Showing results (101-110 of 367) with videos related to

Sort By:
Pageof 37
Pediatric Blood & Cancer|August 26, 2006
Flow cytometric evaluation of platelet activation in chronic autoimmune thrombocytopeniaSimon Panzer, Lisa Höcker, Rainer Vormittag, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 17, 2025
Estimating the Factor VIII-Equivalent Activity of Emicizumab Using Global Assays of HaemostasisDaniel Kraemmer, Cihan Ay, Judit Rejtő, et al.
Scientific Reports|June 22, 2021
Bleeding outcomes and factor utilization after switching to an extended half-life product for prophylaxis in haemophilia A in AustriaCihan Ay, Clemens Feistritzer, Joachim Rettl, et al.
Journal of Thrombosis and Haemostasis : JTH|March 16, 2023
Risk factors for future bleeding in patients with mild bleeding disorders: longitudinal data from the Vienna Bleeding BiobankDino Mehic, Georg Neubauer, Florian Janig, et al.
Hamostaseologie|June 9, 2026
Risk Factors, Biomarkers, and Risk Assessment Models for Prediction of Venous Thromboembolism in Ambulatory Patients with Advanced Lung CancerLeyla Ay, Florian Moik, Thorsten Füreder, et al.
Wiener Klinische Wochenschrift|January 18, 2012
Inhibitor development in two patients with mild haemophilia A - spontaneous disappearance and no recurrence of the inhibitor after re-challengeSylvia Reitter-Pfoertner, Birgit Horvath, Klaus Lechner, et al.
Seminars in Thrombosis and Hemostasis|April 4, 2025
Hemostatic and Inflammatory Biomarkers are Associated with Functional Limitations after Venous Thromboembolism: A Prospective Cohort StudyDaniel Steiner, Stephan Nopp, Timothy Hoberstorfer, et al.
Thrombosis Research|March 3, 2007
The clinical significance of anti-prothrombin antibodies for risk assessment of thromboembolism in patients with lupus anticoagulantThomas Sailer, Rainer Vormittag, Claudia Zoghlami, et al.
Haematologica|March 7, 2007
Venous thromboembolism--a manifestation of the metabolic syndromeCihan Ay, Theres Tengler, Rainer Vormittag, et al.
Thrombosis and Haemostasis|May 6, 2006
Anti-beta2-glycoprotein I antibodies are associated with pregnancy loss in women with the lupus anticoagulantThomas Sailer, Claudia Zoghlami, Christine Kurz, et al.
Pageof 37